Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases.
Oruç Z, Kaplan MA, Karaağaç M, Özyurt N, Tatlı AM, Kaya AO, Menekşe S, Kut E, Koca S, Sever ÖN, Yasin İ, Ebinç S, Zeynelgil E, Sakin A, Turhal NS, Isikdogan A.
Oruç Z, et al. Among authors: ebinc s.
Future Oncol. 2021 May;17(13):1611-1624. doi: 10.2217/fon-2020-1032. Epub 2021 Feb 26.
Future Oncol. 2021.
PMID: 33631986